Homocysteine in chronic atrophic gastritis: a study on immunohistochemical patterns in gastric mucosa
2018-01-01 Crafa, Pellegrino; Noto, Antonino; Miraglia, Chiara; Barchi, Alberto; Campanini, N.; Franzoni, Lorella; Tursi, Antonio; Rugge, Massimo; Brandimarte, Giovanni; Franceschi, Marilisa; Di Mario, Francesco
How can we measure acid secretion in the single patient? A validated non-invasive surrogate test compared with maximal acid output in 600 people
2018-01-01 Miraglia, Chiara; Scida, Serena; Franceschi, Marilisa; Cavatorta, Ottavia; Crafa, Pellegrino; Franzoni, Lorella; Barchi, Alberto; Cannizzaro, Renato; Scarpignato, Carmelo; Di Mario, Francesco
DIASTOLIC FUNCTION EVALUATED BY TISSUE DOPPLER ANALYSIS AND ARTERIAL STIFFNESS AFTER CARDIAC REVASCULARIZATION
2009-01-01 Montemerlo, E; Cafro, A; Capra, A; Canova, P; Pozzi, M; Betelli, M; Cesana, F; Calchera, I; Colombo, V; Formica, F; Paolini, G; Giannattasio, C; Mancia, G
L-ARGININE AND CARDIOPLEGIA: A PROSPECTIVE RANDOMIZED STUDY
2006-01-01 Colagrande, L; Formica, F; Porta, F; Brustia, M; Avalli, L; Sangalli, F; Paolini, G
Favorable Survival of In-Hospital Compared with Out-of-Hospital Refractory Cardiac Arrest Patients Treated with Extracorporeal Membrane Oxygenation: An Italian Tertiary Care Center Experience
2011-01-01 Avalli, L; Greco, G; Sangalli, F; Galbiati, L; Trabucchi, M; Formica, F; Costa, C; Ristagno, G; Fumagalli, R
Effects of papaverine and glyceril-trinitrate/verapamil solution on internal thoracic artery flow: a prospective randomized study
2005-01-01 Brustia, M; Formica, F; Colagrande, L; Corti, F; Bosisio, E; Paolini, G.
BRCA STATUS, MOLECULAR PROFILE AND CLINICAL VARIABLES IN PRIMARY BILATERAL BREAST CANCERS: A POPULATION-BASED CANCER REGISTRY STUDY
2012-01-01 Musolino, A; Bella, Ma; Michiara, M; Zanelli, P; Naldi, N; Bortesi, B; Sgargi, P; Camisa, R; Neri, Tm; Ardizzoni, A
Risk of breast cancer in ovarian cancer patients non-carriers of BRCA1 and BRCA2 mutations with a family history of breast and ovarian cancer: A population-based cancer registry study
2013-01-01 Musolino, A; Boggiani, D; Bella, Ma; Zanelli, P; Naldi, N; Bortesi, B; Sgargi, P; Michiara, M; Ardizzoni, A
DIFFERENT EXPRESSION OF BRCA1 STATUS AND CLINICAL VARIABLES IN A SAMPLE OF ITALIAN WOMEN WITH EARLY ONSET BREAST CANCER (EOBC)
2004-01-01 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Neri, Tm; Savi, M; Bandini, N; Franciosi, V; De Lisi, V; Sgargi, P; Ardizzoni, A; Cascinu, S
Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)
2004-01-01 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Bandini, N; Franciosi, V
BRCA1 and BRCA2 status in a sample of Italian women with early onset breast cancer (EOBC)
2005-01-01 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Cappelletti, M; Neri, Tm; Savi, M; Bandini, N; De Lisi, V; Sgargi, P; Ardizzoni, A
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer
2006-01-01 Musolino, A; Naldi, N; Bortesi, B; Capelletti, M; Pezzuolo, D; Franciosi, D; Missale, G; Laccabue, D; Camisa, R; Ardizzoni, A
Brain metastasis (BM) prediction by transcriptomic profiling in triple-negative breast cancer (TNBC)
2016-01-01 Duchnowska, Renata; Jarzab, Michal; Zebracka, Jadwiga; Matkowski, Rafal; Kowalczyk, Anna; Radecka, Barbara; Foszczynska-Kloda, Malgorzata; Musolino, Antonino; Czartoryska-Arlukowicz, Bogumila; Litwiniuk, Maria Malgorzata; Szablowska-Siwik, Sylwia; Karczmarek-Borowska, Bozenna; Sosinska-Mielcarek, Katarzyna; Chmielowska, Ewa; Olszewski, Wojciech P; Patera, Janusz; Zawrocki, Anton; Rusinek, Dagmara; Jassem, Jacek; Biernat, Wojciech
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
2016-01-01 Musolino, A; Sikokis, A; Boggiani, D; Rimanti, A; Pellegrino, B; Silini, Em; Campanini, N; Barbieri, E; Cortesi, L; Panebianco, M; Porzio, R; Frassoldati, A; Sgargi, P; Falcini, F; Michiara, M
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors
2017-01-01 Migliari, S; Sammartano, A; Pellegrino, B; Regina, V; Cavazzini, D; Ottonello, S; Missale, G; Musolino, A; Ruffini, L
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER
2017-01-01 Conte, Pier Franco; Bisagni, Giancarlo; Frassoldati, Antonio; Brandes, Alba Ariela; Anselmi, Elisa; Giotta, Francesco; Aieta, Michele; Gebbia, Vittorio; Musolino, Antonino; Garrone, Ornella; Taverniti, Cristiana; Cavazzini, Giovanna; Turletti, Anna; Rubino, Daniela; Picardo, Elisa; Ferro, Antonella; Piacentini, Federico; Balduzzi, Sara; D'Amico, Roberto; Guarneri, Valentina
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
2017-01-01 Musolino, Antonino; Porzio, Rosa; Rubino, Daniela; Frassoldati, Antonio; Caldara, Alessia; Schirone, Alessio; Gori, Stefania; Piacentini, Federico; Berardi, Rossana; Brandes, Alba Ariela; Cavazzini, Giovanna; Foglietta, Jennifer; Villa, Federica; Pellegrino, Benedetta; Camisa, Roberta; Todeschini, Renata; Tognetto, Michele; Naldi, Nadia; Baldari, Daniela; Montemurro, Filippo
Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer
2017-01-01 Conte, P.; Conte, P.; Bisagni, G.; Frassoldati, A.; Brandes, A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Musolino, A.; Garrone, O.; Donadio, M.; Cavazzini, G.; Turletti, A.; Zamagni, C.; Danese, S.; Ferro, A.; Piacentini, F.; Balduzzi, S.; D'Amico, R.; Guarneri, V.
Abstract OT1-03-03: Phase II, open label, randomized, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with operable or locally advanced/Inflammatory HER2-positive breast cancer. ImmunHER trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
2018-01-01 Musolino, A; Gori, S; Cavanna, L; Graiff, C; Frassoldati, A; Bria, E; Bisagni, G; Zambelli, A; Partesotti, G; Brandes, A; Bonetti, A; Moscetti, L; Zamagni, C; Rocca, A; Generali, D; Montemurro, F; Gianni, L; Tognetto, M; Maglietta, G; Todeschini, R
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio
2018-01-01 Conte, P. F.; Guarneri, V.; Bisagni, G.; Piacentini, F.; Brandes, A. A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Frassoldati, A.; Musolino, A.; Garrone, O.; Taverniti, C.; Rimanti, A.; Sarti, S.; Rubino, D.; Bologna, A.; Vicini, R.; Balduzzi, S.; D'Amico, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Homocysteine in chronic atrophic gastritis: a study on immunohistochemical patterns in gastric mucosa | 1-gen-2018 | Crafa, Pellegrino; Noto, Antonino; Miraglia, Chiara; Barchi, Alberto; Campanini, N.; Franzoni, Lorella; Tursi, Antonio; Rugge, Massimo; Brandimarte, Giovanni; Franceschi, Marilisa; Di Mario, Francesco | |
| How can we measure acid secretion in the single patient? A validated non-invasive surrogate test compared with maximal acid output in 600 people | 1-gen-2018 | Miraglia, Chiara; Scida, Serena; Franceschi, Marilisa; Cavatorta, Ottavia; Crafa, Pellegrino; Franzoni, Lorella; Barchi, Alberto; Cannizzaro, Renato; Scarpignato, Carmelo; Di Mario, Francesco | |
| DIASTOLIC FUNCTION EVALUATED BY TISSUE DOPPLER ANALYSIS AND ARTERIAL STIFFNESS AFTER CARDIAC REVASCULARIZATION | 1-gen-2009 | Montemerlo, E; Cafro, A; Capra, A; Canova, P; Pozzi, M; Betelli, M; Cesana, F; Calchera, I; Colombo, V; Formica, F; Paolini, G; Giannattasio, C; Mancia, G | |
| L-ARGININE AND CARDIOPLEGIA: A PROSPECTIVE RANDOMIZED STUDY | 1-gen-2006 | Colagrande, L; Formica, F; Porta, F; Brustia, M; Avalli, L; Sangalli, F; Paolini, G | |
| Favorable Survival of In-Hospital Compared with Out-of-Hospital Refractory Cardiac Arrest Patients Treated with Extracorporeal Membrane Oxygenation: An Italian Tertiary Care Center Experience | 1-gen-2011 | Avalli, L; Greco, G; Sangalli, F; Galbiati, L; Trabucchi, M; Formica, F; Costa, C; Ristagno, G; Fumagalli, R | |
| Effects of papaverine and glyceril-trinitrate/verapamil solution on internal thoracic artery flow: a prospective randomized study | 1-gen-2005 | Brustia, M; Formica, F; Colagrande, L; Corti, F; Bosisio, E; Paolini, G. | |
| BRCA STATUS, MOLECULAR PROFILE AND CLINICAL VARIABLES IN PRIMARY BILATERAL BREAST CANCERS: A POPULATION-BASED CANCER REGISTRY STUDY | 1-gen-2012 | Musolino, A; Bella, Ma; Michiara, M; Zanelli, P; Naldi, N; Bortesi, B; Sgargi, P; Camisa, R; Neri, Tm; Ardizzoni, A | |
| Risk of breast cancer in ovarian cancer patients non-carriers of BRCA1 and BRCA2 mutations with a family history of breast and ovarian cancer: A population-based cancer registry study | 1-gen-2013 | Musolino, A; Boggiani, D; Bella, Ma; Zanelli, P; Naldi, N; Bortesi, B; Sgargi, P; Michiara, M; Ardizzoni, A | |
| DIFFERENT EXPRESSION OF BRCA1 STATUS AND CLINICAL VARIABLES IN A SAMPLE OF ITALIAN WOMEN WITH EARLY ONSET BREAST CANCER (EOBC) | 1-gen-2004 | Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Neri, Tm; Savi, M; Bandini, N; Franciosi, V; De Lisi, V; Sgargi, P; Ardizzoni, A; Cascinu, S | |
| Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC) | 1-gen-2004 | Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Bandini, N; Franciosi, V | |
| BRCA1 and BRCA2 status in a sample of Italian women with early onset breast cancer (EOBC) | 1-gen-2005 | Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Cappelletti, M; Neri, Tm; Savi, M; Bandini, N; De Lisi, V; Sgargi, P; Ardizzoni, A | |
| Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer | 1-gen-2006 | Musolino, A; Naldi, N; Bortesi, B; Capelletti, M; Pezzuolo, D; Franciosi, D; Missale, G; Laccabue, D; Camisa, R; Ardizzoni, A | |
| Brain metastasis (BM) prediction by transcriptomic profiling in triple-negative breast cancer (TNBC) | 1-gen-2016 | Duchnowska, Renata; Jarzab, Michal; Zebracka, Jadwiga; Matkowski, Rafal; Kowalczyk, Anna; Radecka, Barbara; Foszczynska-Kloda, Malgorzata; Musolino, Antonino; Czartoryska-Arlukowicz, Bogumila; Litwiniuk, Maria Malgorzata; Szablowska-Siwik, Sylwia; Karczmarek-Borowska, Bozenna; Sosinska-Mielcarek, Katarzyna; Chmielowska, Ewa; Olszewski, Wojciech P; Patera, Janusz; Zawrocki, Anton; Rusinek, Dagmara; Jassem, Jacek; Biernat, Wojciech | |
| Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study | 1-gen-2016 | Musolino, A; Sikokis, A; Boggiani, D; Rimanti, A; Pellegrino, B; Silini, Em; Campanini, N; Barbieri, E; Cortesi, L; Panebianco, M; Porzio, R; Frassoldati, A; Sgargi, P; Falcini, F; Michiara, M | |
| [68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors | 1-gen-2017 | Migliari, S; Sammartano, A; Pellegrino, B; Regina, V; Cavazzini, D; Ottonello, S; Missale, G; Musolino, A; Ruffini, L | |
| 9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER | 1-gen-2017 | Conte, Pier Franco; Bisagni, Giancarlo; Frassoldati, Antonio; Brandes, Alba Ariela; Anselmi, Elisa; Giotta, Francesco; Aieta, Michele; Gebbia, Vittorio; Musolino, Antonino; Garrone, Ornella; Taverniti, Cristiana; Cavazzini, Giovanna; Turletti, Anna; Rubino, Daniela; Picardo, Elisa; Ferro, Antonella; Piacentini, Federico; Balduzzi, Sara; D'Amico, Roberto; Guarneri, Valentina | |
| Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) | 1-gen-2017 | Musolino, Antonino; Porzio, Rosa; Rubino, Daniela; Frassoldati, Antonio; Caldara, Alessia; Schirone, Alessio; Gori, Stefania; Piacentini, Federico; Berardi, Rossana; Brandes, Alba Ariela; Cavazzini, Giovanna; Foglietta, Jennifer; Villa, Federica; Pellegrino, Benedetta; Camisa, Roberta; Todeschini, Renata; Tognetto, Michele; Naldi, Nadia; Baldari, Daniela; Montemurro, Filippo | |
| Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer | 1-gen-2017 | Conte, P.; Conte, P.; Bisagni, G.; Frassoldati, A.; Brandes, A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Musolino, A.; Garrone, O.; Donadio, M.; Cavazzini, G.; Turletti, A.; Zamagni, C.; Danese, S.; Ferro, A.; Piacentini, F.; Balduzzi, S.; D'Amico, R.; Guarneri, V. | |
| Abstract OT1-03-03: Phase II, open label, randomized, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with operable or locally advanced/Inflammatory HER2-positive breast cancer. ImmunHER trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) | 1-gen-2018 | Musolino, A; Gori, S; Cavanna, L; Graiff, C; Frassoldati, A; Bria, E; Bisagni, G; Zambelli, A; Partesotti, G; Brandes, A; Bonetti, A; Moscetti, L; Zamagni, C; Rocca, A; Generali, D; Montemurro, F; Gianni, L; Tognetto, M; Maglietta, G; Todeschini, R | |
| 9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio | 1-gen-2018 | Conte, P. F.; Guarneri, V.; Bisagni, G.; Piacentini, F.; Brandes, A. A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Frassoldati, A.; Musolino, A.; Garrone, O.; Taverniti, C.; Rimanti, A.; Sarti, S.; Rubino, D.; Bologna, A.; Vicini, R.; Balduzzi, S.; D'Amico, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista1767
Data di pubblicazione
- 2020 - 2025192
- 2010 - 2019832
- 2000 - 2009517
- 1990 - 1999174
- 1980 - 198951
- 1979 - 19791
Editore
- ELSEVIER25
- SAGE PUBLICATIONS LTD17
- DIKE GIURIDICA15
- Elsevier13
- ASCO pubs11
- ELSEVIER IRELAND LTD7
- ASCO6
- ELSEVIER SCIENCE INC5
- SAGE5
- SPRINGERNATURE4
Rivista
- DIGESTIVE AND LIVER DISEASE101
- GASTROENTEROLOGY100
- ANNALS OF ONCOLOGY93
- BLOOD89
- JOURNAL OF CLINICAL ONCOLOGY58
- HAEMATOLOGICA56
- NEUROLOGICAL SCIENCES47
- UNITED EUROPEAN GASTROENTEROLOGY ...46
- ANNALS OF THE RHEUMATIC DISEASES36
- REUMATISMO26
Keyword
- Helicobacter pylori10
- sclerosi sistemica6
- Bioengineering5
- Gastroenterology5
- HCV5
- UV5
- GERD4
- Lungs4
- anodal stimulation3
- beat-to-beat variability of cardi...3
Lingua
- eng926
- ita177
- fre1
Accesso al fulltext
- no fulltext1735
- reserved26
- open6